Log in to your Inderes Free account to see all free content on this page.
EQL Pharma
47.30 SEK
-3.47 %
Less than 1K followers
EQL
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-3.47 %
-6.89 %
-23.71 %
-18.17 %
-18.87 %
-39.97 %
+51.12 %
+52.58 %
+780.04 %
EQL Pharma operates in the pharmaceutical industry and focuses on the development, manufacturing and distribution of generic medicines. The company's products are aimed at healthcare institutions and patients who need cost-effective treatment options. The business is global with a primary presence in Europe, North America and Asia. EQL Pharma was founded in 2006 and is headquartered in Lund, Sweden.
Read moreMarket cap
1.4B SEK
Turnover
1.03M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
8.5.
2026
Annual report '26
20.8.
2026
General meeting '26
All
Press releases
3rd party
ShowingAll content types
Invitation to presentation in connection with EQL Pharma's year-end report, fourth quarter, 2025/26
DNB Carnegie Access: EQL Pharma: Recovery continues, but near-term headwinds – Q4 preview
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio